Effects of Chestnuts on Postprandial Glycaemic Response

Launched by MONASH UNIVERSITY · Apr 29, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effects of chestnuts on blood sugar levels after eating, a condition known as postprandial glycemia. Researchers want to learn more about how chestnuts might help improve health, especially for people at risk of diabetes and other chronic diseases. While nuts like walnuts and almonds have been studied before, chestnuts haven't received much attention, even though they are packed with beneficial nutrients like fiber, vitamins, and minerals.

To participate in the study, you need to be an adult aged 18 to 65 and available to come to the research facility for two testing sessions. However, if you have a nut or gluten allergy, certain health conditions, or are pregnant or breastfeeding, you won't be eligible to join. If you do participate, you'll help researchers discover new dietary strategies that could lead to better health outcomes for many people. This study is an exciting opportunity to explore the potential benefits of chestnuts, which are gaining interest in the food industry for their taste and nutritional value.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults 18-65 years old
• • Available to attend two testing sessions at the research facility
• Exclusion Criteria:
• • Allergy to nuts and/or gluten,
• • BMI\<18.5 or ≥30 kg/m2,
• • Fasting glucose \>5.6 mmol/L, presence of diabetes and/or taking anti-diabetic medication
• • Serious health conditions that may affect participation e.g. liver or thyroid dysfunction, recent major surgery,
• • Smoker,
• • Cardiovascular disease
• • Pregnant or breastfeeding women
• • Presence of implanted cardiac defibrillator